| Tretinoin | Approved Investigational Nutraceutical | CRABP1 | 1381 |
upregulated | Tretinoin results in increased expression of CRABP1 mRNA | 15q25.1 | |
| Tretinoin | Approved Investigational Nutraceutical | CRABP2 | 1382 |
upregulated | Tretinoin results in increased expression of CRABP2 mRNA | 1q23.1 | |
| Tretinoin | Approved Investigational Nutraceutical | CRACR2A | 84766 |
downregulated | Tretinoin results in decreased expression of CRACR2A mRNA | 12p13.32 | |
| Tretinoin | Approved Investigational Nutraceutical | CRB1 | 23418 |
upregulated | Tretinoin results in increased expression of CRB1 mRNA | 1q31.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CREB3 | 10488 |
upregulated | Tretinoin results in increased expression of CREB3 mRNA | 9p13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CREB5 | 9586 |
downregulated | Tretinoin results in decreased expression of CREB5 mRNA | 7p15.1-p14.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CREB5 | 9586 |
upregulated | Tretinoin results in increased expression of CREB5 mRNA | 7p15.1-p14.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CREG1 | 8804 |
upregulated | Tretinoin results in increased expression of CREG1 mRNA | 1q24.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CRIM1 | 51232 |
upregulated | Tretinoin results in increased expression of CRIM1 mRNA | 2p22.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CRIPAK | 285464 |
upregulated | Tretinoin results in increased expression of CRIPAK mRNA | 4p16.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CRISPLD1 | 83690 |
upregulated | Tretinoin results in increased expression of CRISPLD1 mRNA | 8q21.13 | |
| Tretinoin | Approved Investigational Nutraceutical | CRMP1 | 1400 |
downregulated | Tretinoin results in decreased expression of CRMP1 mRNA | 4p16.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CRTAC1 | 55118 |
upregulated | Tretinoin results in increased expression of CRTAC1 mRNA | 10q24.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CRTAP | 10491 |
upregulated | Tretinoin results in increased expression of CRTAP mRNA | 3p22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CRY2 | 1408 |
upregulated | Tretinoin results in increased expression of CRY2 mRNA | 11p11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CRYAB | 1410 |
downregulated | Tretinoin results in decreased expression of CRYAB mRNA | 11q23.1 | |
| Tretinoin | Approved Investigational Nutraceutical | CRYAB | 1410 |
upregulated | Tretinoin results in increased expression of CRYAB mRNA | 11q23.1 | |
| Tretinoin | Approved Investigational Nutraceutical | CRYBA2 | 1412 |
downregulated | Tretinoin results in decreased expression of CRYBA2 mRNA | 2q35 | |
| Tretinoin | Approved Investigational Nutraceutical | CRYBB2 | 1415 |
downregulated | Tretinoin results in decreased expression of CRYBB2 mRNA | 22q11.23 | |
| Tretinoin | Approved Investigational Nutraceutical | CRYBG3 | 131544 |
upregulated | Tretinoin results in increased expression of CRYBG3 mRNA | 3q11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CRYL1 | 51084 |
upregulated | Tretinoin results in increased expression of CRYL1 mRNA | 13q12.11 | |
| Tretinoin | Approved Investigational Nutraceutical | CRYM | 1428 |
upregulated | Tretinoin results in increased expression of CRYM mRNA | 16p12.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CSE1L | 1434 |
downregulated | Tretinoin results in decreased expression of CSE1L mRNA | 20q13.13 | |
| Tretinoin | Approved Investigational Nutraceutical | CSF1R | 1436 |
upregulated | Tretinoin results in increased expression of CSF1R mRNA | 5q32 | |
| Tretinoin | Approved Investigational Nutraceutical | CSF3R | 1441 |
upregulated | Tretinoin results in increased expression of CSF3R mRNA | 1p34.3 | |